Chimeric antigen receptor (CAR) T cell therapy has changed the treatment landscape for certain blood cancers. Standardizing CAR T cell manufacturing is one of the key considerations for improving production standards, reducing variability, and maximizing clinical safety and efficacy.
Download this article from Thermo Fisher Scientific to learn how closed, integrated, and automated instrument workflows improve CAR T cell manufacturing.
Top Image Credit:
iStock
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and spot the effects of excipients on protein stability.
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
System strengthens Taiwan’s capabilities in protein drug discovery research
The Transferpette® pro expands the Transferpette® family, offering scientists even greater flexibility to match their pipetting preferences and workflow requirements.
Fast, gentle, and highly specific glycoprotein labeling compatible with downstream immunofluorescence, enabled by next-generation aminooxy chemistry.
Thermo Scientific X and S Series General Purpose Centrifuges are designed to help provide exceptional performance, versatility and enhanced sustainability.
